Letter to the Editor
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Jul 16, 2025; 17(7): 108289
Published online Jul 16, 2025. doi: 10.4253/wjge.v17.i7.108289
Endoscopic resection for esophageal gastrointestinal stromal tumors: Balancing R0 resection and long-term outcomes
Shinichiro Kobayashi, Yuki Muta, Shunsuke Murakami, Kengo Kanetaka
Shinichiro Kobayashi, Yuki Muta, Shunsuke Murakami, Kengo Kanetaka, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan
Co-first authors: Shinichiro Kobayashi and Yuki Muta.
Author contributions: Kobayashi S and Muta Y wrote the original draft and read and approved the final version of the manuscript; Murakami M participated in editing the manuscript; Kanetaka K participated in editing the manuscript and approved the final version.
Conflict-of-interest statement: The authors have no competing interests to declare.
Open Access: This is an open-access article selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, providing that the original work is properly cited and its use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Shinichiro Kobayashi, Associate Professor, FACS, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8501, Japan. skobayashi1980@gmail.com
Received: April 10, 2025
Revised: May 5, 2025
Accepted: June 9, 2025
Published online: July 16, 2025
Processing time: 90 Days and 19.2 Hours
Abstract

Xu et al retrospectively assessed endoscopic resection (ER) for esophageal gastrointestinal stromal tumors (E-GISTs) and reported excellent 5-year survival rates. Although ER shows promise as a minimally invasive procedure, the 75% R0 resection rate with recurrence observed even after R0 resection warrants further discussion. We highlight the need for careful patient selection based on tumor size, location, and risk, considering endoscopic and thoracoscopic approaches. Future studies should refine ER techniques, optimize patient selection, and establish long-term follow-up to guide E-GIST management.

Keywords: Endoscopic resection; Esophagus; Gastrointestinal stromal tumors; Recurrence; R0 resection

Core Tip: Xu et al highlighted the potential of performing endoscopic resection (ER) for esophageal gastrointestinal stromal tumors (E-GISTs). However, the 75% R0 resection rate raises concerns. Although ER offers a minimally invasive access, recurrence after R0 resection underscores the need for careful patient selection. Future studies should refine ER techniques; identify optimal candidates based on tumor size, location, risk, and genetics; and develop algorithms for treatment selection. Long-term follow-up is essential for assessing recurrence and ultimately guiding evidence-based E-GIST management.